Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2996 (LINC02996) is a human long non-coding RNA (lncRNA) gene located on chromosome 5 (GRCh38: 5:42153219-42188157)[1][3][6]. It is recognized by the HGNC with approved gene symbol LINC02996 and affiliated with the lncRNA gene class[1][7]. Synonyms include IGF1R/AK000840 fusion and TCONS_00010315[6]. Its biological function is not well defined and it has not been established as a direct therapeutic target, receptor, enzyme, transporter, or other druggable protein[1][7][12]. Some database entries indicate expression or methylation in chronic lymphocytic leukemia and presence in cancer genomic studies, but there is no evidence for direct targeting with drugs or as a biomarker[12][9][11]. As a long non-coding RNA, it may potentially play a regulatory role in gene expression or chromatin modification, but experimental evidence specific to this transcript is lacking in current databases. Some sources list it in the context of fusion genes (e.g., IGF1R/AK000840 fusion), but details or functional consequences of such fusions are not described in the search results. There is no evidence for established pharmacological manipulation of this lncRNA. Despite the presence of "IGF1R" in one alias, this is not the insulin-like growth factor 1 receptor itself, nor a conventional receptor molecule. No interacting drugs, mechanisms of action, or approved biomarker status are reported in any functional or pharmacological databases[6][7][12].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2996 (LINC02996).